Table 5: Progression-free survival and overall survival according to the management decision guided or unguided by the genomic profiling findings.
|
|
GP-Guided |
GP-Unguided |
Unclear |
P value |
|
Median PFS (95% CI), m |
24 (12.0-36.7) |
26.4 (13.7-39.0) |
Inestimable |
0.17 |
|
|
|
|
|
0.64* |
|
Median OS (95% CI), m |
28.3 (12.4-44.3) |
30.5 (24.4-36.6) |
17.3 (inestimable) |
0.84 |
|
|
|
|
|
0.76* |
|
OS % at 12 and 24 months |
94%, 55% |
83%, 66% |
100%, 0% |
|
*Comparing GP-Guided versus GP-unguided; GP: Genomic Profiling; PFS: Progression-Free Survival; OS: Overall Survival